Man Accused Of Killing His Infant Son

By n cCrossett

Corbin Douglas

Man Accused Of Killing His Infant Son

July 22, 2010 Updated Nov 30, 2005 at 10:47 PM EDT

The prosecution says Corbin Douglas Sr. took his mother’s prescription narcotic painkillers and put some in his infant son’s bottle.

Fourteen-month-old Corbin Douglas Jr. died this past February from a morphine overdose. His father is on trial for allegedly giving the child the drug that killed him.

The prosecution in this case says that only Corbin Douglas Sr. had the opportunity, means, and motive to administer a lethal dose of a narcotic painkiller to his 14-month-old son back in February.

“My theory is that he’s crying. He wants to get up; dad wants to sleep, so dad gives him a little morphine to put him to sleep, but he gives him too much,” said John Mueh, Otsego County District Attorney.

The Defense questioned the credibility of the witness who identified a narcotic painkiller that is evidence in the case as the bottle he saw Douglas Sr. pour into the child’s baby bottle. The witness, a Chenango County jail inmate, admitted he was in a drug-induced fog much of the weekend the child was killed.

“We’re pretty sure his testimony isn’t going to add up in the end when you combine it with some toxicology tests, and that’s going to lead this jury to start speculating and guessing, perhaps,” said Defense Attorney William Schebaum.

The defense attorney says the evidence will show toxicology tests failed to detect any drug residue in the baby’s bottle. Perhaps the most compelling testimony will come from the defendant himself. His attorney says he will take the stand later this week or early next week, and he’ll deny the charges.

The prosecution says that evidence will show the child's arm was broken, and that the injury is consistent with abuse.

Testimony will resume in this case on Thursday.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.